THIS SHARE WILL BE WORTH 3.00 IN 2009

Some day traders must be making/loosing a mint on this. All down to timing. Can't read this share or the market at all of late.

No news appeared so I'm continuing to steer clear of this - too unpredictable

Must agree. Anyone buying/selling at the moment is taking a big chance.
I'm treating this as a hold.

Always nice to see step progress in any trial.
'First patient being treated in its expanded phase 2 programme of CytoFabTM in severe sepsis'. Hopefully for both patents and investors alike, in 12 months the results will be successful.

So another step in progress in a different trial (2 within 3 days) and the sp drops.
Could it be the fact that early 2010 has been mentioned for results of said trial has put people off. Can't understand why some people buy into the likes of Protherics if they don't understand drug time scales. It cant even be profit takers as there are more recorded buys than sells.
Me, I will just sit tight and hopefully have the last laugh.

Nice write up re the cancer trial in Pharmalife.http://www.medadnews.com/News/Index.cfm?articleid=508527

A very good update, especially with the dollar earnings being hit by the drop in that currency. Looking forward to the next set of results, expecting something really sp positive (news).

Yes but I expect selling today yet again - we never get any momentum going in this market. Hold on though something will inginte eventually!1

Hi Transco,

Fully agree. With the market as is latterly, most shares are on the yo yo merry go round. (can you have such a thing?)

indeed you can greek, i would go so far as to say it's a yo yo merry go round rollercoaster! and either we're going to throw up or really enjoy the ride. you need a strong stomach for this one . i believe whitestar (15/2/06) has probably got it right. regards parthus

Anyone any idea why the big drop today of 4p (7.27%).
Been out all day but can't find any reason.
Aware that the SP has been like a yo yo almost daily over last few months but a 4p drop still appears strange.

The market didn't like this then - down over 10% today...

Protherics said its placebo-controlled Phase 2b Digoxin Immune Fab (DIF) study to treat severe pre-eclampsia has met one of its two primary endpoints. Severe pre-eclampsia is a potentially life-threatening complication of pregnancy for which there is currently no effective treatment other than delivery.

Chief executive Andrew Heath, however, said the results from this small and complex study are not conclusive and added that further analysis of the full data will be required to determine the direction of the programme.

I feel the drop is over reaction and expect a recovery over the next few day making up at least half of the loss.

this is a rubbish share why I hold on I will never know!!

Not exactly a stated recommendation to buy, but on reading the article that is the impression given.http://www.pr-inside.com/protherics-plc-corporate-and-strategic-r708336.htm

Geek - Well I have held on for this long...The slump from 40's to low 30's is in line with the market slump but it must be overdone. Then again take your pick on undervalued companies - lots to choose from.
The failure of Phase 2b Digoxin Immune Fab (DIF) didnt go down well.

Morning Transco,

Fully agree the test results did not go down well. I think many did look on the results as a total failure, but they were not fully successful which is not quite the same. The tests did result in meeting 1 of the 2 targets.
The group's chief executive Andrew Heath said the results from this small and complex study are not conclusive and added that further analysis of the full data will be required to determine the direction of the programme.
As has been said many times on this thread, many punters want almost instant success, and in the current market conditions any bad news knocks the sp more than warranted.
As you also say "It must be overdone".
Protherics is on my list of the companies for increasing exposure. just waiting till the time is right. I feel that will be when the value of Protherics as a company(especially the potential) takes over from the market view as a whole.

I have averaged down only to lose more - if only on paper.
We need good news flow but nothing expected till end of year early next.
Iwill sit tight.

This is a Pharma, with all the risks associated wiith trials - it's very much a wait and see. Some income from rattlesnake divn, so at least shareholders shouldn't see (much) dilution, unlike most other Bio's.
I've held this for a while and this Market dip is rather worse than I expected, so maybe an av dn is looming - but then maybe not. Are you L-T transco15...? I read you're none to happy (earlier posts)......so why did you buy originially?

Well I thought if the big boys were interseted in backing them so should I - I was wrong i think!